Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Masahiko Uchida"'
Autor:
Taichi Nakamura, Tetsuhide Ito, Hisato Igarashi, Masahiko Uchida, Masayuki Hijioka, Takamasa Oono, Nao Fujimori, Yusuke Niina, Koichi Suzuki, Robert T. Jensen, Ryoichi Takayanagi
Publikováno v:
International Journal of Inflammation, Vol 2012 (2012)
Pancreatitis is an inflammatory disease of unknown causes. There are many triggers causing pancreatitis, such as alcohol, common bile duct stone, virus and congenital or acquired stenosis of main pancreatic duct, which often involve tissue injuries.
Externí odkaz:
https://doaj.org/article/5cfd46f9c1004b47aa61c9718396f1f8
Autor:
Ryoichi Takayanagi, Robert T. Jensen, Taichi Nakamura, Koichi Suzuki, Takamasa Oono, Ken Kawabe, Masahiko Uchida, Nao Fujimori, Hisato Igarashi, Tetsuhide Ito
Publikováno v:
Laboratory Investigation. 93:41-53
The clinical course of chronic pancreatitis (CP) worsens with drinking, and pancreatic stellate cells (PSCs) have an important role in the pathogenesis of alcoholic CP. Chemokines recruit inflammatory cells, resulting in chronic pancreatic inflammati
Autor:
Ryo Shimoda, Nanae Tsuruoka, Ryuichi Iwakiri, Takashi Akutagawa, Yasuhisa Sakata, Shimpei Shirai, Kazuma Fujimoto, Kohei Yamanouchi, Masahiko Uchida
Publikováno v:
Internal medicine (Tokyo, Japan). 55(12)
We herein report a case of Cronkhite-Canada syndrome (CCS) complicated with triple primary cancers. The patient was diagnosed with CCS at 65 years of age. At 76 years of age, one of his colon polyps was diagnosed as adenocarcinoma. At 81 years of age
Autor:
Hisato Igarashi, Takamasa Oono, Masayuki Hijioka, Ringaku Lee, Taichi Nakamura, Kazuhiro Kotoh, Nao Fujimori, Masahiko Uchida, Kazuhiko Nakamura, Risa Iwao, Yusuke Niina, Ryoichi Takayanagi, Tetsuhide Ito
Publikováno v:
Journal of Digestive Diseases. 13:274-279
OBJECTIVE: We aimed to investigate the relationship between the number of involved organs or regions and serum immunoglobulin G (IgG) and immunoglobulin G4 (IgG4) levels. METHODS: The number of pancreatic and/or extrapancreatic lesions and serum IgG
Autor:
Robert T. Jensen, Takamasa Oono, Taichi Nakamura, David H. Coy, Tetsuhide Ito, Nao Fujimori, Masahiko Uchida, Ryoichi Takayanagi, Hisato Igarashi
Publikováno v:
Peptides. 32:2067-2076
Vasoactive intestinal peptide (VIP) attenuates experimental acute pancreatitis (AP) by inhibition of cytokine production from inflammatory cells. It has been suggested that reactive oxygen species (ROS) as well as cytokines play pivotal roles in the
Autor:
Nao Fujimori, Mikihiko Yasuda, Yusuke Niina, Ryoichi Takayanagi, Takamasa Oono, Masahiko Uchida, Koichi Suzuki, Taichi Nakamura, Tetsuhide Ito, Hisato Igarashi
Publikováno v:
Pancreas. 40:823-831
We hoped to clarify the possible role of CpG DNA as a trigger factor for overt pancreatic inflammation of pancreatic stellate cells (PSCs).Pancreatic stellate cells were isolated from the male Lewis rat. The expression of Toll-like receptor 9 (TLR9)
Autor:
Tetsuhide Ito, Tooru Shimosegawa, Takamasa Oono, Yusuke Niina, Ryoichi Takayanagi, Masahiko Uchida, Hisato Igarashi, Makoto Otsuki, Isao Nishimori, Taichi Nakamura, Ken Kawabe, Nao Fujimori
Publikováno v:
Journal of Digestive Diseases. 12:210-216
OBJECTIVE: Although patients with autoimmune pancreatitis (AIP) tend to have concurrent diverse disorders, very few studies have focused on diabetes mellitus (DM) coexisting with AIP. METHODS: In total 102 AIP patients with DM were divided into three
Publikováno v:
The Proceedings of the Symposium on sports and human dynamics. 2010:175-178
Autor:
Nao Fujimori, Tetsuhide Ito, Takamasa Ono, Mikihiko Yasuda, Yusuke Niina, Ryoichi Takayanagi, Masahiko Uchida, Taichi Nakamura, Hisato Igarashi
Publikováno v:
Nihon Naika Gakkai Zasshi. 99:56-61
Autor:
Kiyoto Hara, Masami Kojima, Satoshi Akahane, Takashi Koizumi, Toshiki Honma, Yuji Hoyano, Masahiko Uchida, Masuo Akahane
Publikováno v:
Journal of Health Science. 49:368-378
A Cynomolgus monkey hemodialysis model was used to evaluate the efficacy of a new factor Xa (FXa) inhibitor as an anticoagulant for hemodialysis. We tested the selective FXa inhibitor KFA-1411, using doses of 0.15 mg/ kg/hr, 0.3 mg/kg/hr, and 0.6 mg/